Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
VANCOUVER, British Columbia and BOSTON, MA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, ...
BEDMINSTER, N.J., Dec. 1, 2025 /PRNewswire/ -- Biocodex, a global pharmaceutical company and long-time pioneer in the treatment of rare pediatric diseases, will present 12 studies at the upcoming AES ...
Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of seizure freedom with long-term use of azetukalner Data will also highlight ...
PLYMOUTH MEETING - Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) will present new open-label extension data from its Phase 3 ARGUS trial investigating EPX-100 (clemizole hydrochloride) for the ...
Lundbeck to present comprehensive new bexicaserin dataset in patients with rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting · New data to be presented at the 2025 AES ...
Bright Minds Biosciences is a biotechnology company developing innovative treatments for patients with neurological and psychiatric disorders. Our pipeline includes novel compounds targeting key ...
NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results